CSF3 and cancer: Neutralisation of IL-6/G-CSF was able to prevent docetaxel-induced activation of dormant cancer cells in vivo; however, it remains to be determined if IL-6/G-CSF inhibition can revert awakened cancer cells to a dormant state.